Is CAR-T Cell a Relapsed Hodgkin Lymphoma?

The AFM drug, which is this by this tetravalent molecule that links CD56 ONK cells with CD30. We've seen data on this agent before, which really wasn't that impressive. It was combined with Pembroelysumab. And to be honest, it looked just as good as Pembroesumab monotherapy. But what they're doing now is ex vivo. They're taking some NK cells and coupling this drug to these NK cells. Very interesting.